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Cough Suppression Strategies
• relaxed/open throat breathing
• sip water 
• hard swallow 
• breath hold
Baseline Testing
• Determine cough sensitivity on healthy control: by measuring 
the amount of inhaled capsaicin that causes two coughs (C2) 
and five coughs (C5)2
• Teach behavioral cough suppression techniques (BCST) ask 
participants to practice relaxed throat breathing twice a day
Methods
Treatment Sessions
• 3x/week for two weeks
• Practice BCST following inhalation of capsaicin at increasing 
doses
Post-treatment Testing
• Retest cough sensitivity one week and three weeks post-
treatment 
Research Question
Is it possible to decrease cough sensitivity by 
exposing patients to increasing doses of 
aerosolized capsaicin (a known cough stimulant) 
combined with active cough suppression?
Introduction 
About 10-20% of patients who suffer from 
chronic cough do not respond to medical 
treatment4. They are said to have refractory 
chronic cough (RCC). Research has shown the 
underlying cause of RCC in many patients is 
hypersensitivity in the airway leading this subset 
of cough to be called cough hypersensitivity 
syndrome (CHS) 3.  Many patients with CHS are 
successfully treated with behavioral cough 
suppression therapy (BCST). BCST primarily 
consists of suppressing the cough. Within 2-4 
weeks the sensitivity returns to normal. Experts 
theorize the change is due to the use-it or lose-it 
principle of neuroplasticity1. Although BCST is 
an effective treatment in up to 88% of patients 
with RCC4, some patients have such a strong 
urge-to -cough (UTC) they cannot suppress it at 
all. We hypothesize these patients would benefit 
from BCST is they could be presented with 
cough stimulant strong enough to elicit UTC but 
weak enough for cough suppression. 
Purpose
The purpose of this study was to determine 
feasibility of decreasing cough sensitivity 
through use of cough suppression strategies 
following inhalation of capsaicin in gradually 
increasing doses, across repeated treatment 
sessions. 
VOICES (Voice Outcomes and Inquiry of 
Cough and Essentials in Swallowing) Lab
Results 
All 3 subjects were able to successfully 
suppress their cough at the highest capsaicin dose 
(1000 uM) after treatment sessions. Post-treatment 
testing 1 week following treatment revealed a 
significant decrease in cough sensitivity for all 3 
participants. In general C2 did not change as much 
as C5. 
Future Directions
This study shows feasibility of testing 
programmatic desensitization coupled with cough 
suppression in a larger sample with a placebo 
group. Similar results in a larger sample with 
placebo will provide a rationale for testing on 
patients with CHS. Ultimately, if this treatment 
works, it could significantly change how CHS is 
treated in the future. 
Participants
3 healthy controls (no respiratory issues) recruited 
from CSD department 
